Ayahuasca: A Comprehensive Guide to the Experience, Risks, and Therapeutic Potential

What Is Ayahuasca?

Any honest ayahuasca guide has to start with the basics, because the brew is widely misunderstood. Ayahuasca is a traditional Amazonian preparation, usually made by combining two plants: the Banisteriopsis caapi vine and the leaves of Psychotria viridis (or a similar DMT-containing plant). It has been used for centuries by Indigenous peoples across the Amazon basin in ceremonial and healing contexts. In the last two decades, it has drawn growing interest from researchers and from professionals looking beyond conventional mental health treatment.

What makes ayahuasca distinct from other psychedelics is its pharmacology. The active psychedelic compound is N,N-dimethyltryptamine (DMT), which on its own is broken down almost immediately in the gut by an enzyme called monoamine oxidase. The Banisteriopsis caapi vine contains beta-carboline alkaloids, mainly harmine, harmaline, and tetrahydroharmine, which temporarily inhibit that enzyme. This is what allows DMT to survive digestion, enter the bloodstream, and reach the brain when taken orally. The result is a psychedelic experience that can last four to six hours, far longer than smoked or vaporized DMT.

How Does Ayahuasca Work in the Brain and Body?

Once DMT reaches the brain, it acts on serotonin receptors, particularly the 5-HT2A receptor that is central to most classic psychedelics. Activating this receptor appears to loosen the brain’s usual patterns of activity, including the network responsible for our ongoing sense of self and rumination. Researchers studying ayahuasca have observed reduced activity in this network during the experience, which may help explain why people often report a temporary shift in how they relate to their own thoughts and memories.

The beta-carbolines in the vine are not just passive enablers. By inhibiting monoamine oxidase, they also raise levels of serotonin and other neurotransmitters throughout the body. This dual action is part of what gives ayahuasca its character, and it is also the source of its most serious risks. The same mechanism that makes the brew work is the mechanism that makes it dangerous to combine with certain medications, a point we return to below.

There is also early interest in whether ayahuasca promotes neuroplasticity, the brain’s capacity to form new connections. Some laboratory work suggests the beta-carbolines may support this process. What this means in practical terms is still an open question, and it would be a mistake to present it as settled. The honest summary is that the mechanisms are partly understood and partly still being mapped.

What Is the Ayahuasca Experience Actually Like?

People who drink ayahuasca describe a wide range of experiences, and that variability is itself worth understanding. The onset typically begins within 30 to 60 minutes. Effects build over the first hour or two, peak in the middle, and gradually subside over four to six hours. Many ceremonies involve more than one cup, which can extend the timeline.

Visual phenomena are common, ranging from geometric patterns to vivid imagery. Just as common, and often more significant, are the emotional and psychological dimensions: the surfacing of old memories, strong feelings, and a sense of confronting unresolved material. Many people describe the experience as demanding rather than pleasant. It is frequently more like difficult inner work than recreation.

Physical effects are a normal part of the experience, not a sign that something has gone wrong. Nausea and vomiting are so common that they have a traditional name, “la purga,” the purge, and are often framed within ceremony as part of the process. Diarrhea, sweating, changes in heart rate, and shifts in body temperature also occur. None of this is incidental. It is one reason ayahuasca is not something to approach casually or alone.

What Does the Research on Ayahuasca and Depression Show?

The most rigorous clinical evidence to date comes from a randomized, placebo-controlled trial conducted in Brazil and published in Psychological Medicine in 2019. Researchers gave 29 patients with treatment-resistant depression a single dose of either ayahuasca or a placebo. The group that received ayahuasca showed significantly greater reductions in depression scores than the placebo group, with benefits observed as early as one day after the session and still present at the seven-day follow-up. This was the first study of its kind to use a placebo control, which is what makes it meaningful rather than merely suggestive.

Earlier open-label studies, where everyone knew they were receiving ayahuasca, pointed in the same direction, reporting rapid reductions in depression symptoms that lasted up to three weeks. These results are encouraging. They are also early. The sample sizes are small, the follow-up periods are short, and a single controlled trial, however well designed, is not the same as an established treatment.

Here is what we can say with confidence: the early signal is real and worth taking seriously, particularly for depression that has not responded to standard treatment. Here is what we cannot say: that ayahuasca is a proven therapy, that its effects are durable over months and years, or that it is appropriate for any given individual. Anyone presenting ayahuasca as a guaranteed solution is overstating the evidence.

What Are the Risks and Contraindications?

This is the part that matters most. The brew’s safety profile is more complicated than that of several other psychedelics, precisely because of the monoamine oxidase inhibitors it contains.

The most urgent concern is medication interactions. Because ayahuasca acts as a monoamine oxidase inhibitor and raises serotonin levels, combining it with antidepressants that also affect serotonin, including SSRIs and SNRIs, can trigger serotonin syndrome. This is a potentially life-threatening condition involving confusion, rapid heart rate, high blood pressure, muscle rigidity, high body temperature, and in severe cases seizures. Combining ayahuasca with other monoamine oxidase inhibitors carries a similar danger, including the risk of a hypertensive crisis. Many medications need to be tapered and fully cleared from the body well in advance, and that tapering must be done under the supervision of a prescribing physician, never independently.

Cardiovascular risk is the second major concern. Ayahuasca raises heart rate and blood pressure, which can be dangerous for people with existing heart conditions. A personal or family history of psychotic disorders or bipolar disorder is also a strong reason for caution, since psychedelics can precipitate or worsen these conditions in vulnerable individuals. Pregnancy is a clear contraindication.

These are not edge cases to be waved away. They are the reason that medical screening is not optional. A full list of medical contraindications, including conditions that warrant a firm stop versus a careful conversation, is covered in our guide to who should pause before pursuing psychedelic therapy. The interaction between psychedelics and antidepressants in particular deserves its own careful read.

Why Do Set, Setting, and Support Matter So Much Here?

With a substance this long, this intense, and this physically demanding, the surrounding conditions are not optional extras. They are the foundation of a safer experience. “Set” refers to a person’s internal state, mindset, intention, and emotional readiness. “Setting” refers to the physical and relational environment. For a deeper treatment of how these two factors shape an experience, see our guide to set and setting in psychedelic preparation.

The presence of experienced, trustworthy support is the single most important safety factor in any ayahuasca context. This matters for screening beforehand, for monitoring during the experience, and for the integration work afterward, where the insights from a session are translated into lasting change. Much of the work of ayahuasca, when it works, happens in the weeks after the experience, not during it.

It is worth being direct about the realities of access. Ayahuasca is not legal for general therapeutic use in the United States, and most people who pursue it do so at retreats abroad or in unregulated settings. That landscape varies widely in quality and safety. If you are weighing a retreat in another country, our overview of how to evaluate safety at a psychedelic retreat abroad walks through the questions that actually matter. The difference between a well-screened, professionally supported experience and an unvetted one is not a matter of preference. It can be a matter of safety.

Is Ayahuasca Right for You?

There is no general answer to that question, and anyone who offers one without knowing your medical history and your reasons for considering it is not being straight with you. What we can say is that the decision deserves careful thought, honest medical screening, and grounded conversation before anything else. Ayahuasca is neither a miracle nor a danger to be dismissed. It is a powerful tool with real promise and real risks, and the difference between those two outcomes usually comes down to preparation, screening, and support.